Addressing large, unmet global markets with innovative proprietary products More »
Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »
Identifying early-stage companies with potential to increase value for shareholders More »
OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors.
OPKO Submits Investigational New Drug Application to Initiate a Phase 2a Trial for its Long-Acting Coagulation Factor VIIa-CTP to Treat Hemophilia more »
OPKO and Pfizer Receive Regulatory Clearance for Global Agreement more »
OPKO Launches the 4Kscore Test in Mexico more »
OPKO Health is an opportunistic research and development company that targets large, high-growth markets.